Nimodipine is a Oral Capsule, Liquid Filled in the Human Prescription Drug category. It is labeled and distributed by Mckesson Corporation Dba Sky Packaging. The primary component is Nimodipine.
| Product ID | 63739-797_2dc6a343-a97a-43e9-8d90-2fdb2ec7a795 |
| NDC | 63739-797 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Nimodipine |
| Generic Name | Nimodipine |
| Dosage Form | Capsule, Liquid Filled |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-01-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA090103 |
| Labeler Name | McKesson Corporation dba SKY Packaging |
| Substance Name | NIMODIPINE |
| Active Ingredient Strength | 30 mg/1 |
| Pharm Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2016-12-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA090103 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-12-29 |
| Ingredient | Strength |
|---|---|
| NIMODIPINE | 30 mg/1 |
| SPL SET ID: | 18855589-5063-484f-a064-cb1110833302 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0904-6566 | Nimodipine | Nimodipine |
| 23155-108 | Nimodipine | Nimodipine |
| 23155-512 | nimodipine | nimodipine |
| 55154-4184 | Nimodipine | Nimodipine |
| 57664-135 | Nimodipine | Nimodipine |
| 62559-210 | Nimodipine | Nimodipine |
| 63739-797 | Nimodipine | Nimodipine |
| 67877-297 | Nimodipine | Nimodipine |
| 68084-912 | Nimodipine | Nimodipine |
| 69452-209 | Nimodipine | Nimodipine |
| 24338-200 | Nymalize | nimodipine |
| 24338-205 | Nymalize | nimodipine |
| 24338-230 | Nymalize | nimodipine |
| 24338-260 | Nymalize | nimodipine |